Evidence map›Paper›PMID 24041719›Full record

ReviewThe Journal of steroid biochemistry and molecular biology2014

The immune system in menopause: pros and cons of hormone therapy.

Mimi Ghosh, Marta Rodriguez-Garcia, Charles R Wira

Abstract readReview
In one paragraph

Review in The Journal of steroid biochemistry and molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 4 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 4 syntheses or guidelines pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Menopause and "leaky gut": implications for midlife women's health.The Journal of clinical investigation · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mimi GhoshDepartment of Epidemiology and Biostatistics, The George Washington University, Washington, DC 20037, USA. Electronic address: mghosh@gwu.edu.
Marta Rodriguez-GarciaDepartment of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Charles R WiraDepartment of Physiology and Neurobiology, Geisel School of Medicine at Dartmouth, Lebanon, NH 03756, USA.
Dartmouth College · USGeorge Washington University · US

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
The influence of steroid sex hormones and gender on pmnP01AI051877 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 2002 to 2006
$7.4M
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial CellsR01AI071761 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 2007 to 2014
$2.6M
Menstrual Cycle Control of HIV Infection in the Reproductive TractR01AI102838 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 2012 to 2016
$2.2M
Innate Immune Protection Against HIV-1 by Reproductive Tract Epithelial CellsR56AI071761 · NIAID · DARTMOUTH COLLEGE · PI WIRA, CHARLES ROBERT · 2007 to 2007
$167k
Anti-HIV activity in genital tract secretions of postmenopausal womenR03AI102837 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI GHOSH, MIMI · 2012 to 2013
$166k
NCI NIH HHS P30 CA023108NIAID NIH HHS AI071761NIAID NIH HHS AI102837NIAID NIH HHS AI51877NIAID NIH HHS P01 AI051877NIAID NIH HHS R01 AI071761NIAID NIH HHS R01 AI102838NIAID NIH HHS R03 AI102837NIAID NIH HHS R56 AI071761
6 · The paper itself

Abstract

With aging, a general decline in immune function is observed leading to immune-senescence. Several of these changes are gender specific affecting postmenopausal women. Menopause is a normal part of a woman's lifecycle and consists of a series of body changes that can last from one to ten years. It is known that loss of sex hormones due to aging results in a reduction of immune functions. However, there remains a major gap in our understanding regarding the loss of immune functions particularly in the female reproductive tract (FRT) following menopause and the role of menopausal hormone therapy (MHT) in protecting against immune senescence. The current review presents an overview of changes in the immune system due to aging, focusing on genital tract immunity in menopausal women and the risks and benefits of using MHT. This article is part of a Special Issue entitled 'Menopause'.

Indexed as

Adaptive ImmunityAdultAgingAnimalsEstradiolEstrogen Replacement TherapyFemaleGenitalia, FemaleGonadal Steroid HormonesHumansImmune SystemImmunity, InnateInfectionsMenopauseMiddle AgedProgesteroneEstradiolGonadal Steroid HormonesProgesteroneEstrogenFemale reproductive tractHIVImmunityMenopausal hormone therapyMenopauseProgesterone

Identifiers

PMID24041719
PMCPMC3954964
OpenAlexW2047944451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.